XML 37 R22.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value (Tables)
9 Months Ended
Sep. 30, 2019
Fair Value [Abstract]  
Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis The following table represents the Company’s fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2019:

Quoted Prices in
Active Markets for
Identical Assets
(Level 1)

Significant Other
Observable Inputs
(Level 2)

Significant Other
Unobservable
Inputs (Level 3)

Total

Assets:

Money market funds

$

$

3,300

$

$

3,300

Repurchase agreements

10,000

10,000

Commercial paper

16,677

16,677

U.S. government agencies and securities

9,029

9,029

Corporate bonds

24,874

24,874

Asset-backed securities

16,331

16,331

Total assets

$

9,029

$

71,182

$

$

80,211

Liabilities:

Acquisition-related contingent consideration

183,139

183,139

Total liabilities

$

$

$

183,139

$

183,139

There were no changes in the levels or methodology of measurement of financial assets and liabilities during the three and nine months ended September 30, 2019.

The following table represents the Company’s fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2018:

Quoted Prices in
Active Markets for
Identical Assets
(Level 1)

Significant Other
Observable Inputs
(Level 2)

Significant Other
Unobservable
Inputs (Level 3)

Total

Assets:

Money market funds

$

$

16,193

$

$

16,193

Commercial paper

40,731

40,731

U.S. government agencies and securities

6,734

6,734

Corporate bonds

30,195

30,195

Asset-backed securities

14,511

14,511

Total assets

$

6,734

$

101,630

$

$

108,364

Liabilities:

Acquisition-related contingent consideration

18,773

18,773

Total liabilities

$

$

$

18,773

$

18,773

Level 3 Fair Value Measurements Using Significant Other Unobservable Inputs for Acquisition-Related Contingent Consideration

Nine Months Ended

Twelve Months Ended

September 30, 2019

December 31, 2018

Beginning Balance

$

18,773

$

37,098

Amounts acquired

171,300

Settlement of trial enrollment milestone

(7,500)

Changes in fair value included in earnings

(6,934)

(10,825)

Ending Balance

$

183,139

$

18,773